Ashley McEvoy - Feb 10, 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
Raavi K. Deol, as attorney-in-fact for Ashley McEvoy
Stock symbol
JNJ
Transactions as of
Feb 10, 2023
Transactions value $
-$133,392
Form type
4
Date filed
2/14/2023, 03:36 PM
Previous filing
Dec 2, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +3K +7.17% $0.00 44.8K Feb 10, 2023 Direct F1
transaction JNJ Common Stock Tax liability -$133K -823 -1.84% $162.08 44K Feb 10, 2023 Direct F2
holding JNJ Common Stock 2.72K Feb 10, 2023 By 401k F3
holding JNJ Common Stock 300 Feb 10, 2023 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -3K -100% $0.00* 0 Feb 10, 2023 Common Stock 3K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).